| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.6 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |